These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids. Fyffe SA; Alphey MS; Buetow L; Smith TK; Ferguson MA; Sørensen MD; Björkling F; Hunter WN J Mol Biol; 2006 Mar; 356(4):1005-13. PubMed ID: 16405912 [TBL] [Abstract][Full Text] [Related]
4. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery. Perez Diaz N; Lione LA; Hutter V; Mackenzie LS Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880 [TBL] [Abstract][Full Text] [Related]
5. Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor β/δ. Li CH; Ren XM; Cao LY; Qin WP; Guo LH Environ Sci Process Impacts; 2019 Nov; 21(11):1908-1914. PubMed ID: 31332417 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121 [TBL] [Abstract][Full Text] [Related]
7. The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation. Iannotti FA; Vitale RM Cells; 2021 Mar; 10(3):. PubMed ID: 33799988 [TBL] [Abstract][Full Text] [Related]
8. Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form. Fyffe SA; Alphey MS; Buetow L; Smith TK; Ferguson MA; Sørensen MD; Björkling F; Hunter WN Mol Cell; 2006 Jan; 21(1):1-2. PubMed ID: 16387648 [No Abstract] [Full Text] [Related]
9. Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype. Kuwabara N; Oyama T; Tomioka D; Ohashi M; Yanagisawa J; Shimizu T; Miyachi H J Med Chem; 2012 Jan; 55(2):893-902. PubMed ID: 22185225 [TBL] [Abstract][Full Text] [Related]
10. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid. Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617 [TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha. Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129 [TBL] [Abstract][Full Text] [Related]
12. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor. Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940 [TBL] [Abstract][Full Text] [Related]
13. PPAR Beta/Delta and the Hallmarks of Cancer. Wagner N; Wagner KD Cells; 2020 May; 9(5):. PubMed ID: 32375405 [TBL] [Abstract][Full Text] [Related]
14. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis. Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995 [TBL] [Abstract][Full Text] [Related]
15. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury. Chehaibi K; le Maire L; Bradoni S; Escola JC; Blanco-Vaca F; Slimane MN Transl Res; 2017 Apr; 182():27-48. PubMed ID: 27818230 [TBL] [Abstract][Full Text] [Related]
17. Ombuin-3-O-β-D-glucopyranoside from Gynostemma pentaphyllum is a dual agonistic ligand of peroxisome proliferator-activated receptors α and δ/β. Malek MA; Hoang MH; Jia Y; Lee JH; Jun HJ; Lee DH; Lee HJ; Lee C; Lee MK; Hwang BY; Lee SJ Biochem Biophys Res Commun; 2013 Jan; 430(4):1322-8. PubMed ID: 23247028 [TBL] [Abstract][Full Text] [Related]
18. Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function. Giordano Attianese GM; Desvergne B Nucl Recept Signal; 2015; 13():e001. PubMed ID: 25945080 [TBL] [Abstract][Full Text] [Related]